title: Clostridium difficile infection may loom behind ipilimumab-induced auto-immune colitis.
authors.forename: Aurélie
authors.initials: A
authors.lastname: Du-Thanh
authors.forename: Valérie
authors.initials: V
authors.lastname: Pallure
authors.forename: Céline
authors.initials: C
authors.lastname: Girard
authors.forename: Olivier
authors.initials: O
authors.lastname: Dereure
authors.forename: Bernard
authors.initials: B
authors.lastname: Guillot
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001327:Autoimmune Diseases / Q000139:chemically induced* / Q000150:complications; D016360:Clostridioides difficile; D003015:Clostridium Infections / Q000150:complications*; D003092:Colitis / Q000139:chemically induced* / Q000150:complications; D003967:Diarrhea / Q000139:chemically induced; D005260:Female; D006801:Humans; D000074324:Ipilimumab
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D000074324:Ipilimumab